BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/26/2024 7:20:28 AM | Browse: 194 | Download: 564
 |
Received |
|
2024-08-20 02:14 |
|
Peer-Review Started |
|
2024-08-13 14:37 |
|
First Decision by Editorial Office Director |
|
2024-09-27 02:32 |
|
Return for Revision |
|
2024-09-27 02:32 |
|
Revised |
|
2024-10-01 18:58 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-11-01 02:37 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-11-01 06:15 |
|
Articles in Press |
|
2024-11-01 06:15 |
|
Edit the Manuscript by Language Editor |
|
2024-11-07 19:15 |
|
Typeset the Manuscript |
|
2024-11-11 02:29 |
|
Publish the Manuscript Online |
|
2024-11-26 07:20 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Inflammatory biomarkers as cost-effective predictive tools in metabolic dysfunction-associated fatty liver disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Davide Ramoni, Luca Liberale and Fabrizio Montecucco |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Fabrizio Montecucco, MD, PhD, Department of Internal Medicine, First Clinic of Internal Medicine, IRCCS Ospedale Policlinico San Martino, Italian Cardiovascular Network, 6 Viale Benedetto XV, Genoa 16132, Italy. fabrizio.montecucco@unige.it |
| Key Words |
Adipokines; Cardiometabolic risk assessment; Inflammatory biomarkers; Metabolic dysfunction-associated fatty liver disease; Metabolic syndrome; Osteopontin |
| Core Tip |
Metabolic dysfunction-associated fatty liver disease is a rapidly growing condition that requires the identification of non-invasive diagnostic tools, particularly biomarkers that are readily detectable and cost-effective. In this article, we focused on inflammation-related biomarkers, which show promise due to their ability to impact both metabolic and cardiovascular diseases. Integrating these non-invasive tools into the clinical practice can reinforce risk stratification and facilitate early intervention. This approach not only enhances patient outcomes but also addresses the rising prevalence of metabolic dysfunction-associated fatty liver disease. Continued research is essential to validate these biomarkers in clinical practice and to improve the management and personalization of care strategies. |
| Publish Date |
2024-11-26 07:20 |
| Citation |
Ramoni D, Liberale L, Montecucco F. Inflammatory biomarkers as cost-effective predictive tools in metabolic dysfunction-associated fatty liver disease. World J Gastroenterol 2024; 30(47): 5086-5091 |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i47/5086.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i47.5086 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
